New York Assembly Bill A01461

New York 2025-2026 Regular Session

• Introduced: 1/9/25
• Refer: 1/9/25
• Report Pass: 4/28/25
• Refer: 4/28/25
• Report Pass: 5/13/25

Caption

Relates to the use of antipsychotic medications in nursing homes; imposes limits as to time and documentation; requires informed consent under certain circumstances.

Impact

If enacted, A01461 will significantly impact the process by which healthcare is administered to residents in nursing homes. By imposing strict documentation and consent requirements, the bill aims to enhance the rights of residents and promote a culture of transparency within facilities. Proponents argue that this will lead to better healthcare practices and protect vulnerable residents from inappropriate medication use. However, the bill may also create additional administrative burdens for healthcare professionals and facilities, as they will need to ensure compliance with the new consent requirements, potentially leading to delays in treatment during critical situations.

Summary

A01461 is a legislative bill that aims to amend the public health law regarding the administration of antipsychotic medications in nursing homes and adult care facilities. The bill stipulates that before initiating the administration of such medications, informed written consent must be obtained from the resident or their lawful representative. This requirement is intended to empower residents and ensure that they or their representatives are fully informed about the medications, their potential benefits, side effects, and the right to consent or refuse treatment. The bill specifies certain exceptions where consent is not required, such as in emergency situations or when a resident has been previously prescribed the medication within a specified time frame.

Contention

The discussion surrounding A01461 encompasses various viewpoints. Supporters, particularly from advocacy groups and parent organizations, stress the importance of safeguarding resident rights and reducing the over-reliance on chemical restraints in nursing homes. Critics, including some healthcare officials, express concern that the stringent requirements may hinder timely care for residents with acute needs or emergencies. There may also be fears that the implementation of such regulations could limit the ability of healthcare professionals to make prompt medical decisions in the best interest of their patients, leading to complications in treatment protocols.